Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Affiliations

• ¹ Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
• ² Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
• ³ Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
• ⁴ Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
• ⁵ Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
• ⁶ Rain Therapeutics Inc, Newark, CA, USA.
• ⁷ Department of Biomedical Research, Urology Group, University of Bern, Bern, Switzerland.
• ⁸ Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie Research Center, Paris, France.
• ⁹ Department of Pathology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
• ¹⁰ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
• ¹¹ Division of Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ¹² Department of Medical Oncology, Institut Curie, Saint Cloud, France.
• ¹³ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. [email protected].
• ¹⁴ Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland. [email protected].
• ¹⁵ SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. [email protected].
• ¹⁶ Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. [email protected].
• ¹⁷ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. [email protected].